TABLE 2.

Comparison of the frequencies of COVID‐19 associated telogen effluvium in various groups

Comparison of the frequencies of COVID‐19 associated telogen effluvium in various groups	Frequency of CATE (%)	p
In hospitalized patients	31.7	0.238
In outpatients	24.3
In women	42.3	<0.001 *
In men	6.2
In patients with hypertension	40.4	0.014 *
In patients without hypertension	23.1
In patients with diabetes mellitus	36.1	0.229
In patients without diabetes mellitus	26.2
In patients who have had respiratory symptoms during COVID‐19	31.7	0.021 *
In patients who have not had respiratory symptoms during COVID‐19	14.0
In patients who have had fever during COVID‐19	29.0	0.665
In patients who have not had fever during COVID‐19	26.3

Abbreviation: CATE, COVID‐19 associated telogen effluvium.

^* p < 0.05.